In ovarian clear cell carcinoma (OCCC), PIK3CA activating mutations occur concurrently with ARID1A deletion mutations (51), and mutations in PIK3CA are present in 46% of ARID1A deletion tumors (52). The gene discussed is ARID1A; the disease is ovarian clear cell cancer.